Rheumatoid arthritis (RA) is a chronic autoimmune inflammatory disease characterized by persistent synovitis, progressive joint destruction, and systemic manifestations. Early diagnosis and assessment of disease activity remain essential for preventing irreversible structural damage and improving long-term outcomes. In recent years, antibodies to carbamylated proteins (anti-CarP antibodies) have emerged as promising serological biomarkers in RA. Anti-CarP antibodies are detected in both seropositive and seronegative RA and may precede clinical disease onset. Numerous studies have demonstrated associations between anti-CarP antibodies and disease activity, radiographic progression, bone destruction, and disability. This review summarizes current data regarding the immunopathogenesis, diagnostic value, and clinical significance of anti-CarP antibodies as indicators of disease activity in RA.
Antibodies To Carbamylated Proteins As A Indicators Of Disease In Activity Rheumatoid Arthritis
DOI:
Keywords:
Abstract
References
Abrikosov, A. I., and Strukov, A. I. (1953). Pathological anatomy. Part 1. General pathological processes. Medgiz, 107-133.
Association of serum anti-carbamylated protein antibodies with disease activity and bone loss in rheumatoid arthritis. Clinica Chimica Acta. 2023.
Balabanova, R. M. (1997). Rheumatoid arthritis. Rheumatic diseases (pp. 257-295).
Clinical and pathophysiologic relevance of autoantibodies in rheumatoid arthritis. Advances in Rheumatology. 2018. Rheumatoid arthritis: emerging genetic and immunologic biomarkers. Clinica Chimica Acta. 2026.
Coniglio, P. et al. Autoantibodies in inflammatory arthritis. Autoimmune Rev. 15 (7), 673-683 (2016). [ DOI ] [ PubMed ] [ Google Scholar ]
Derksen, V.F.A.M., Huizinga, T.V.J., and van der Voode, D. The Role of Autoantibodies in the Pathophysiology of Rheumatoid Arthritis. SeminImmunopathol. 39 (4), 437-446 (2017). [ DOI ] [ Free PMC Article ] [ PubMed ] [ Google Scholar ]
Dydykina, I. S., Muraviev, Yu. V., Mamistova, A. I., Novoselova, T. M. (2000). Character of registered side effects occurring in patients during treatment at the Clinic of the Rheumatology Institute of the Russian Academy of Medical Sciences. Scientific and Practical Rheumatology, 4, 46.
Kopeva, T. N. (1980). Pathology of rheumatoid arthritis. In A. I. Strukova (ed.), Medicine (pp. 196-205).
Li L., et al. Meta-Analysis: Diagnostic Accuracy of Anti-Carbamylated Protein Antibody for Rheumatoid Arthritis. PLOS ONE. 2016.
Li X., et al. Diagnostic Accuracy of Anti-Carbamylated Protein Antibodies in Rheumatoid Arthritis: a Systematic Review and Meta-Analysis. Clinical Laboratory. 2019.
Nakaphan P., et al. Diagnostic accuracy of anti-carbamylated protein antibodies in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatology International. 2025.
Network Meta-Analysis of Novel Diagnostic Biomarkers for Rheumatoid Arthritis. Frontiers in Immunology. 2026.
Wang, Z. et al. Protein carbamylation links inflammation, smoking, uremia, and atherogenesis. Nat Med. 13, 1176–1184 (2007). [ DOI ] [ PubMed ] [ Google Scholar]
Winkel, A. et al. Kinetics of carbamyllized hemoglobin in acute renal failure. Nephrol Dial Transplant. 15, 1183–1188 (2000). [ DOI ] [ PubMed ] [ Google Scholar ]